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Abstract Background: The elderly are under-represent-
ed in series of patients operated on for colorectal liver
metastases (LM). Objective: To analyse the influence of
age on surgery of colorectal LM, and the identification
of factors that could be used as exclusion criteria. Pa-
tients and methods: Six hundred and forty-eight patients
underwent liver resection between 1990 and 2006. De-
mographic data, primary tumour related variables, stage
of the disease, morbidity, mortality, survival and recur-
rence were prospectively recorded. Results: One hun-
dred and sixty of 648 patients (25%) were 70 years old
or older. Postoperative mortality was significantly high-
er in elderly patients (8% vs. 3%, p=0.008). Morbidity
was also higher (41% vs. 34%, p=0.008). Survival rate
at 1, 3 and 5 years was 88%, 62% and 45% respectively
in patients younger than 70 years, and 82%, 48% and
36% in the elderly (p=0.007). Excluding the postopera-
tive mortality, the figures were 90%, 64% and 46%.
90%, 53% and 38% (p=0.061). Disease-free survival
rates at 1, 3 and 5 years excluding postoperative mortal-
ity were 68%, 32% and 25% in younger patients, com-
pared to 68%, 34% and 30% (p=0.71) in the elderly.
Major liver resections increased mortality in the elderly.
In the multivariate analyses only a tumour size equal to
or more than 10 cm significantly increased the postop-
erative mortality risk in elderly patients. Conclusions:
The elderly have a higher mortality. In recent years that
difference has been markedly reduced. Excluding the
postoperative mortality, the overall survival and disease-
free survival are similar between both groups. The crite-
ria to indicate surgery must be the same in both groups.
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Introduction
Ageing of the population is a major health problem that
affects western society and its importance has been
steadily increasing in the last decades. Consequently, an
increasing number of elderly patients need surgical
treatment. The specific inconveniences and difficulties
related to that situation have been analysed in diverse
publications dealing with different kinds of surgical in-
terventions [1, 2].
In the field of liver surgery in the elderly, the most
frequent indication consists of colorectal liver metas-
tases (LM). Taking into account that more than 50% of
colorectal carcinomas (CRC) are diagnosed in patients
older than 70 years [3], the logical consequence would
be that between 30% and 50% of patients with LM from
this origin would belong to that age group. However, in
the published series, only 8–15% of patients treated by
hepatic resections are older than 70 years [3–6]. This
difference suggests that, despite the evidence that con-
firms the safety of hepatic surgery in the elderly [4, 5,
7–9], an important percentage of these patients are not
referred for curative surgical treatment. This is probably
because oncologists still have doubts about the possible
benefits that liver surgery can obtain in this group of pa-
tients. These benefits would be counterbalanced by an
increased postoperative morbid/mortality and by the
limited life expectancy of elderly patients.
The primary objective of this study was to evaluate
the influence of old age on the results of surgery of col-
orectal LM. We also tried to identify those staging vari-
ables of the disease that could contraindicate liver sur-
gery in the elderly.
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Patients and methods
Between January 1990 and June 2006, 648 patients un-
derwent surgery for LM of CRC at both centres partici-
pating in the study. The patients were classified into two
groups according to age. The first group included 488
patients younger than 70 years, and the second 160 pa-
tients aged 70 years or older. As expected, through the
prolonged period of the study, many changes have been
introduced in the surgical technique and postoperative
care, along with a constant increase in the expertise of
the surgical team and anaesthesiologists. To assess the
possible influence introduced by these changes, we de-
cided to divide our experience into two groups. In the
first were included the first 200 hepatectomies per-
formed during the period 1990–1998, and in the second,
the remaining resections. During this second period, the
number of liver resections was more than 50 cases per
year. In the same period we introduced systematically
diverse aspects of surgical technique and perioperative
care that can contribute to improvements in the results.
Among them: ultrasonic dissector (CUSA, Tyco Health-
care, Mansfield, MA), hilar intermittent clamping for
periods of 15 min followed by 5-min reperfusion peri-
ods, Central Venous Pressure lower than 5 mmHg dur-
ing the phase of liver transection, and techniques to
maintain normothermia during the intervention.
Demographic data, primary tumour characteristics,
surgical technique, histopathology of the resected liver
specimen, postoperative evolution and results related to
recurrence and survival were obtained from a prospec-
tively collected database maintained from the beginning
of our experience.
The criteria used to indicate the surgical treatment
and the surgical technique were the same for all patients
included in the study at both participating centres. Se-
lection criteria for liver resection included medical fit-
ness for major surgery with no sign of disseminated dis-
ease on preoperative imaging. There were no predefined
criteria for resectability with regard to the number or
size of the tumours, bilobarity, locoregional invasion or
the presence of extrahepatic disease, except that resec-
tion had the potential to be complete and macroscopi-
cally curative. The preoperative imaging studies were
abdominal dual-phase (portal and equilibrium) helical
computed tomography (CT). Details of the technique
and results have been reported previously [10]. Dissemi-
nated disease was ruled out by CT of the chest and
pelvis. Colonoscopy was repeated in the absence of a
normal examination. PET/CT FDG was performed dur-
ing the last four years in patients suspected of present-
ing extrahepatic disease. The histopathological report of
the primary tumour was reviewed in order to confirm
that the first resection was complete. Biochemical pro-
f ile included blood count, measurements of serum
transaminases, bilirubin, carcinoembryonic antigen
(CEA) and CA 19-9 tumour markers, and blood coagu-
lation. Radiographic studies were reviewed at a twice-
weekly multidisciplinary meeting and surgical resection
was scheduled if considered appropriate. All patients
gave written informed consent to undergo surgery.
Patients with synchronous hepatic metastases were
considered for partial colectomy and hepatic resection.
The criteria for chemotherapy were the same at both in-
stitutions. All patients were referred to their oncologist
to evaluate the indication of adjuvant chemotherapy.
Preoperative evaluation was made by the anaesthesiolo-
gy department, consulting other specialists whenever it
was considered appropriate. A portal venous embolisa-
tion was indicated in those cases where the future hepat-
ic remnant was expected to be less than 30%.
Definitions
Postoperative mortality: All deaths during the first 30
days following the surgical procedure, or during the
same hospital admission in those cases in which hospi-
tal stay was longer than 30 days.
Postoperative hepatic failure: The presence of two or
more of the following: prothrombin time ratio >2, jaun-
dice with bilirubin levels >50 μmol/l on the 5th day, as-
cites that needed treatment or encephalopathy [11].
Major hepatectomy: The resection of 3 or more seg-
ments according to Couinaud’s nomenclature.
The surgical technique used for major hepatectomies
included previous ligature and section of the correspon-
ding branch of the hepatic artery, portal vein and biliary
duct. Hilar clamping, total or selective, was indicated on
an individual basis. In patients with chronic hepatopathy
or with cirrhotic liver and in older patients the use of se-
lective clamping was preferred when a minor hepatic re-
section was indicated [12, 13]. In those cases in which to-
tal hilar clamping was indicated, it consisted of ischaemic
periods of 15 min followed by 5 min of reperfusion.
Follow-up
After the first liver resection, all patients were followed
every 6 months with liver function tests, helical CT,
CEA and CA19-9 levels. Colonoscopy was performed
every two years. Repeat hepatectomy was considered if
further liver recurrence was technically resectable and if
helical CT scan of the chest, abdomen and pelvis re-
vealed no unresectable extrahepatic recurrence. The re-
sectability of recurrences in the lung was discussed with
the thoracic surgeons. Any recurrences that were
deemed operable were resected, including locoregional
or anastomotic recurrences. During the last 6 years, ra-
diofrequency (RF) interstitial destruction was used in
combination with resection for otherwise unresectable
patients [14].
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Statistical analyses
Categorical data were analysed using Fisher’s exact test.
Continuous data are expressed as mean (SD) and were
analysed using the unpaired Student’s t-test. Overall sur-
vival was estimated using the Kaplan–Meier method
and compared with log-rank test. Two-tailed level of sig-
nificance was defined as p<0.05. Multivariate logistic
regression was used to detect prognostic factors of post-
operative mortality. Data were managed using a SPSS
software package (SPSS Inc, Chicago, IL).
Results
Elderly patients represented 25% of patients in our se-
ries, but this percentage increased from 18% to 28%
(p=0.008) from the first time period to the second. The
mean age was 73.7 years in the elderly. 57.6 years in the
younger group. We did not find significant differences
between groups in terms of staging of the primary tu-
mour, indication of adjuvant chemotherapy after colonic
surgery and neoadjuvant chemotherapy before liver sur-
gery (Table 1).
The results related to the surgical technique such as
the type of liver resection, duration of the procedure, ne-
cessity of blood or plasma transfusion and utilisation of
RF were all similar in both age groups, as was the post-
operative hospital stay (Table 2).
The proportion of patients with extrahepatic disease
was 15% among the elderly and 16% in the younger
group (p=0.49). The localisation of the extrahepatic dis-
ease was not different between groups (Table 3).
Staging of the disease
The main differences were observed in the staging of
the liver disease (Table 4). Synchronous metastases
were less frequent, and the interval between colonic and
hepatic surgery longer (19.8±26 vs. 13.8±14.7 months,
p=0.001) in the elderly group.
The number of LM was lower among the elderly.
Isolated LM was found in 51% vs. 42% in the elderly
and younger groups respectively (p=0.03). However, the
size of the LM was significantly greater in the elderly
than in the younger group (4.2±2.6 vs. 3.7±2.1 cm;
p=0.009). Lesions larger than 10 cm occurred in 5% vs.
1% in the elderly and younger patients, respectively.
Postoperative outcome
Postoperative mortality was greater in the elderly (8% p
3%, p=0.008). The morbidity was also greater (41% vs.
34%, p=0.008), mainly due to a higher incidence of res-
piratory complications (Table 5). However, these differ-
ences in mortality and morbidity disappeared in the sec-
ond study period (5.6% vs. 2.5%, p=013 for mortality
Table 1 Epidemiological and oncological data of the primary tumour. Numbers in parenthesis are percentages
Patients older than 70 years
No (n=488) Yes (n=160) p
Gender male (%) 307 (63) 119 (74) 0.009
Age years±SD 57.6 ± 8.4 73.7 ± 3 0.00
Primary rectum 176 (36) 54 (34) 0.33
Preoperative CEA ng/ml±SD 34.5 ± 71 39.5 ± 73 0.55
Dukes stage
A 10 (2) 1 0.157
B 161 (33) 64 (40)
C 313 (65) 94 (59)
pT1 10 (2) 0 0.85
pT2 43 (9) 16 (10)
pT3 43 (70) 121 (76)
pT4 12 (20) 21 (13)
pT1+pT2 53 (11) 17 (11) 0.51
pT3+pT4 426 (89) 142 (89)
pN0 171 (36) 68 (43) 0.26
pN1 190 (39) 56 (35)
pN2 121 (25) 35 (22)
pN0 171 (36) 68 (43) 0.06
pN1+pN2 311 (64) 91 (57)
Lymph nodes positives for CRC 2.36±3 2.3±3.2 0.86
Adjuvant Ch after CRC operation 258 (54) 86 (54) 1
POPE 24 (5) 3 (2) 0.11
Neoadjuvant Ch before hepatectomy 130 (27) 32 (20) 0.06
pT, pN, Pathological Classification of the International Union Against Cancer. POPE, preoperative portal embolisation
Table 2 Surgical data. Numbers in parenthesis are percentages
Patients older than 70 years
No (n=488) Yes (n=160) p
Simultaneous surgery 50 (10) 11 (7) 0.13
Hepatectomy technique 0.75
Extended hepatectomy 66 (14) 11 (1)
Right hepatectomy 116 (24) 41 (26)
Left hepatectomy 53 (11) 19 (12)
Bi- or unisegmentectomy 132 (27) 48 (20)
Limited resection 62 (13) 56 (35)
Others 57 (12) 24 (15)
RF only 2 1
Major hepatectomy 292 (60) 95 (59) 1
RF complementary 40 (8) 14 (9) 0.87
No Pringle 51 (11) 18 (11) 0.85
Duration of hilar clamping (minutes) 35.7±22 33±21 0.18
Transfusion 74 (15) 27 (17) 0.32
Duration of surgery 274±80 269±64 0.48
Postoperative stay 11.4±7.7 12.3±11 0.4
RF, radiofrequency ablation
Table 3 Extrahepatic disease. Numbers in parenthesis are percentages
Patients older than 70 years
No (n=488) Yes (n=160) p
Extrahepatic disease 76 (16) 24 (15) 0.49
Locoregional recurrence 19 (4) 3 (2) 0.17
Pedicular lymph nodes 12 (3) 5 (3) 0.41
Carcinomatosis 8 (2) 1 0.31
Pulmonary metastasis 30 (6) 6 (4) 0.05
Diaphragmatic invasion 10 (2) 8 (5) 0.06
Others 5 (1) 1 0.54
Several extrahepatic sites 6 (1) 0 0.18
Table 4 Pathological data. Numbers in parenthesis are percentages
Patients older than 70 years
No (n=488) Yes (n=160) p
Synchronic presentation 239 (49) 63 (39) 0.036
Interval CRC and hepatectomy (months), mean±SD 13.8±14.7 19.8±26 0.000
Bilobar situation 211 (43) 59 (37) 0.09
Number of LM, mean±SD 2.8±2.9 2.2±1.9 0.03
Solitary LM 204 (42) 81 (51) 0.03
LM≥4 120 (25) 29 (18) 0.05
Size (cm) mean±SD 3.7±2.1 4.2±2.6 0.009
Size >5 cm 98 (20) 40 (25) 0.11
Size >10 cm 7 (1) 8 (5) 0.02
Margin (cm), mean±SD 0.99±0.8 1±1 0.95
Margin invasion 65 (13) 24 (15) 0.33
and 37% vs. 30%, p=0.17 for complications). On the
contrary, in the first 200 hepatectomies a higher mortal-
ity was observed among the elderly (14% vs. 3%,
p=0.018). No differences were found either in the inci-
dence of postoperative hepatic failure or in the other
complications directly related to the hepatectomy.
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Survival and recurrence
The mean time of follow-up was 31±28.8 months, al-
though it was slightly less in the elderly group (24±23
vs. 33±30 months). Survival rates at 1, 3 and 5 years
were 88%, 62% and 45% respectively in the younger
group, and 82%, 48% and 36% respectively in the elder-
ly group (p=0.0069) (Fig. 1). Excluding postoperative
mortality the figures were 90%, 64% and 46% vs. 90%,
53% and 38% (p=0.061) (Fig. 2).
During the follow-up, recurrence of the disease was
diagnosed in 46% and 57% of elderly and younger pa-
tients respectively (p=0.012). These differences could be
explained by a higher incidence of hepatic and loco-re-
gional recurrences in the younger group (Table 6). Only
50% of the elderly patients received adjuvant chemothe-
rapy compared to 70% in the younger group (p<0.001).
Disease-free survival rates, excluding the postop-
erative mortality, at 1, 3 and 5 years were 68%, 32%
and 25% for the younger group whilst they were 68%,
34% and 30% in the elderly group (p=0.71) (Fig. 3).
The incidence of hepatic recurrence was also similar:
25%, 47% and 50% vs. 22%, 43% and 46% (p=0.47)
(Fig. 4).
Prognostic factors
None of the variables associated with hepatic staging of
the disease (synchronous metastases, bilobar disease,
number of LM >4, size >10 cm) significantly influ-
enced the long-term survival.
In the univariate analyses of the preoperative vari-
ables related to postoperative mortality in patients older
than 70 years, two significant risk factors of mortality
were identif ied: major hepatic resection (11.6% vs.
1.6%, p=0.028) and a tumoral size >10 cm (37.5% vs.
5.9%, p=0.015).
Table 5 Mortality and morbidity. Numbers in parenthesis are percentages
Patients older than 70 years
No (n=488) Yes (n=160) p
Mortality 13 (3) 12 (8) 0.008
Morbidity 164 (34) 66 (41) 0.05
Wound infection 27 (6) 9 (6) 0.55
Biliary fistula 38 (8) 17 (11) 0.17
Intrabdominal abscess 34 (7) 8 (5) 0.25
Pneumonia 4 (1) 7 (4) 0.007
Haemoperitoneum 8 (2) 2 (1) 0.53
Hepatic insufficiency 41 (8) 18 (11) 0.18
Others 61 (14) 26 (18) 0.12
Reoperation 18 (4) 5 (3) 0.48
Readmission 24 (5) 6 (4) 0.08
Fig. 1 Actuarial patient survival in young (<70 years) and old
patients (>70 years) Fig. 2 Actuarial patient survival excluding postoperative mor-
talities in young (<70 years) and old patients (>70 years)
Age >75 years, number of lesions, previous neoadju-
vant chemotherapy, bilobar localisation and extrahepatic
disease were also analysed. None of these factors was as-
sociated with a higher postoperative mortality (Table 7).
In the multivariate analyses through the logistic re-
gression model, only tumoral size larger than 10 cm sig-
nificantly increased the postoperative mortality risk in
the elderly group (Table 8). When the same model was
applied to the younger group, none of the variables
reached statistical significance.
Discussion
Many publications have suggested that major abdominal
surgery due to cancer can be performed safely in elderly
patients with good results and the preoperative selection
must be based on physiologic criteria and performance
status rather than on chronological aspects [2, 15, 16].
However, in the publication of Polanczyk et al. [1], in
which 4315 patients were included and stratified into 4
age groups, after adjusting for functional status and type
of surgery, they concluded that elderly patients have an
increased risk of postoperative complications. Age was
an independent predictive factor of prolonged hospital
stay in a multivariate predictive model in which vari-
ables such as sex, race, ASA classification and type of
surgical procedure were included. In the results of this
study the high prevalence of non-cardiac perioperative,
especially respiratory, complications is notorious.
Therefore, the assessment of the perioperative risk
should not be focused solely on cardiac risk. This obser-
vation is coincident with our experience, in which the
frequency of respiratory complications in elderly pa-
tients was significantly higher than in younger patients.
The evident higher fragility in elderly patients makes
careful selection of candidates for major surgery neces-
sary. With this objective in mind, several score systems
can be used to assess the operative risk such as the
Physiologic and Operative Severity Score for the enU-
meration of Mortality and Morbidity (POSSUM) [17] or
the Acute Physiology and Chronic Health Evaluation
(APACHE) [18]. Models to predict specifically the post-
Table 6 Outcome and recurrence. Numbers in parenthesis are percentages
Patients older than 70 years
No (n=488) Yes (n=160) p
Recurrence 278 (57) 74 (46) 0.012
Liver 175 (36) 45 (28) 0.044
Pulmonary 122 (25) 32 (20) 0.11
Loco-regional 100 (21) 19 (12) 0.008
Others 71 (15) 22 (14) 0.46
Multiple sites 125 (26) 35 (22) 0.19
Adjuvant chemotherapy 315 (70) 72 (50) 0.000
Fig. 3 Actuarial disease-free survival in young (<70 years) and
old patients (>70 years)
Fig. 4 Specific hepatic recurrence rate in young (<70 years)
and old patients (>70 years)
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operative mortality in elderly patients operated for CRC
have been designed [19]. It would be desirable to devel-
op new specific predictive systems for liver surgery in
the future. The reduction in postoperative morbid/mor-
tality in our series is probably due to a better selection
of patients and improvements in postoperative care in-
troduced in recent years.
Surgery offers the only chance for cure in patients
with colorectal LM. Those patients without treatment
have a mean survival rate of 4–7 months, and those
treated by chemotherapy, 9–22 months. Therefore, all
patients with this pathology should be considered for
surgical treatment, regardless of their age. However, the
low frequency of synchronous LM diagnosed in our eld-
Table 7 Factors related with mortality in patients older than 70 years
Factors Mortality (%) p
Gender Male (n=119) 7.6 0.95
Female (n=41) 7.3
Primary Colon (n=106) 8.5 0.5
Rectum (n=54) 5.6
Dukes A (n=1) 0
B (n=64) 6.3
C (n=94) 7.4
Dukes A+B (n=65) 7.6
C (n=94) 7.4
Type of LM Synchronic (n=63) 7.9 0.86
Metachronic (n=97) 7.2
Interval CRC & LM operation <12 months (n=20) 5.3 0.3
>12 months (n=43) 9.5
Size <5 cm (n=120) 5.0 0.04
>5 cm (n=40) 15.0
<10 cm (n=152) 5.9 0.01
>10 cm (n=8) 37.5
Number of LM Solitary (n=81) 6.2 0.5
>1 LM (n=79) 9.0
<4 LM (n=131) 6.9 0.52
≥4 LM (n=29) 10.3
Adjuvant chemotherapy post CRC operation Yes (n=86) 8.1% 0.52
No (n=74) 5.6
Bilobar Yes (n=59) 10.2 0.32
No (n=101) 5.9
POPE Yes (n=3) 66.7 <0.001
No (n=157) 6.4
Neoadjuvant chemotherapy Yes (n=32) 9.4 0.65
No (n=128) 7.0
Liver resection Major (n=95) 11.6 0.02
Minor (n=65) 1.6
Simultaneous surgery of CRC and LM Yes (n=11) 0 0.33
No (n=149) 8.1
Extrahepatic disease Yes (n=24) 8.3 0.86
No (n=138) 7.4
Margin invasion Yes (n=24) 12.5 0.32
No (n=136) 6.7
Morbidity Yes (n=66) 18.2 <0.001
No (n=94) 0
Reoperation Yes (n=5) 40 0.005
No (n=155) 6.5
POPE, preoperative portal embolisation
Table 8 Factors related with postoperative mortality in patients older than 70 years
p Risk ratio 95% CI
Type of hepatectomy (major vs. minor) 0.057 8.06 0.94 68.96
Size of tumour (≥10 cm vs. <10 cm) 0.035 5.95 1.13 31.25
Age 0.11 1.17 0.96 1.43
Gender 0.80 1.19 0.27 5.14
erly patients suggests that possibly the initial staging is
less exhaustive than in younger patients. Furthermore,
the higher frequency of tumours larger than 10 cm sug-
gests that follow-up is less strict.
Fortunately, if we take into account only the last 200
cases, the percentage of elderly patients with diagnoses
of synchronous LM reaches 45% and patients with tu-
mours larger than 10 cm is less than 2%. Therefore, we
can conclude that in recent years, an important change
of attitude toward the diagnoses and follow-up of these
patients has taken place.
One of the reasons that could explain the “surgical
nihilism” in elderly patients with LM of CRC is the as-
sumption that the livers of these patients do not tolerate
surgery in the same way those of younger patients do.
Regarding this, there is some classical experimental
evidence that the ageing process is associated with de-
terioration of hepatic function as a consequence of mi-
tochondrial [20] and Kupffer cell alterations [21]. How-
ever, two recent clinical studies [7, 8] demonstrated that
the there was no significant difference in evolution of
various biochemical parameters (prothrombin time,
bilirubin, transaminases, gamma-glutamyl transpepti-
dase and alkaline phosphatase) after a right hepatectomy
between two different age groups. In our experience, the
incidence of postoperative hepatic failure was not high-
er in the elderly patients, despite a similar percentage of
major liver resections. Other evidence in favour of the
important functional reserve and capacity of regenera-
tion of the liver in the elderly is their frequent use in ca-
daveric liver transplant.
Despite the previous statement, and our results, the
performance of major hepatic resections in elderly pa-
tients represents an evident increase in the mortality
risk. This increase is especially significant in those pa-
tients with large metastases that need major resections.
Although in our recent results the risk seems to be di-
minishing, we think it is reasonable to recommend that
the future hepatic remnant be larger than the usually
recommended 30%. This objective can be achieved in
some cases by a combination of limited resections and
RF ablation.
The second reason to doubt the benefits of surgery in
elderly patients is their reduced life expectancy and the
idea that death will occur by non-tumoral causes during
the follow-up. With respect to this, Turrini et al. [22]
compared the evolution of two groups of patients aged
between 70 and 80 years, all of them with less than four
resectable metachronous LM. The first group consisted
of 15 patients treated by hepatectomies and without
neoadjuvant chemotherapy to avoid deterioration in liver
function. The second group consisted of 18 patients
treated only with chemotherapy due to a high periopera-
tive risk. The survival rates at 2 years were respectively
73% and 50% (p=0.04). With a median follow-up of 49
months, no patients died of a cause other than colorectal
cancer disease during observation time. It can be con-
cluded that the resection of LM offers benefits in terms
of survival compared to non-operated elderly patients.
From our data we can conclude, excluding the post-
operative mortality, that the results of overall survival,
disease-free survival and hepatic recurrence are not sig-
nificantly different when compared with those obtained
in younger patients.
The results obtained with repeat hepatic resections
due to recurrences of LM in the elderly group did not
allow us to draw clear conclusions. However, it seems
reasonable to avoid surgery whenever extrahepatic dis-
ease is detected. In the experience published by Zacha-
rias et al. [4], all patients in whom a repeat resection
was performed died before 5 years and all recurred
within 3 years. RFA could be an alternative treatment in
these cases.
Conclusions
In our experience, mortality after surgery for colorectal
LM in patients older than 70 years is increased com-
pared with younger patients. This difference in mortality
between different age groups is no longer significant in
our recent experience. Mortality is caused mainly by
non-hepatic complications. It is important to design pro-
tocols of selection and perioperative care in order to de-
crease the incidence of these causes of mortality. Major
hepatic resections in the elderly are associated with an
increased risk of perioperative mortality. The long-term
results of surgical treatment of colorectal LM are the
same as those that can be obtained in younger patients,
therefore the criteria to indicate hepatic surgery should
be the same in both groups.
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